Plasma volume (RIHSA) and peripheral plasma renin activity (Pickens' method) were measured in eight essential hypertensive patients treated with thiazide diuretics alone for periods ranging from 6 to 24 months. Treatment was then stopped and measurements repeated at weekly intervals for a month. During the first week of discontinuance, body weight and plasma volume rose in all (P < 0.001 for both), while peripheral plasma renin activity fell from 3.66 to 1.04 ng/ml (P < 0.005), and serum sodium concentration was practically unchanged. Over the next 3 weeks, both plasma volume and body weight gradually fell from the high first week "rebound" values to plateau at levels higher than those obtained during treatment (2741 vs. 2567 ml, P < 0.001 and 76.1 vs. 74.7 kg, P < 0.001, respectively). At the same time, peripheral plasma renin activity remained stable and markedly lower than during treatment (P <0.001), while blood pressure gradually rose. Extracellular water (ECW) was measured serially (radiobromine) in five patients; in all, body weight variations were completely accounted for by changes in ECW, and ratio of plasma to interstitial fluid volume remained stable. These data indicate that blood pressure reduction by longterm thiazide therapy was associated with persistent plasma volume contraction and occurred despite increased peripheral renin activity. There was no evidence for chronic intracellular dehydration, and variations in peripheral renin activity were related to changes in plasma volume and not to serum sodium concentration.
SUMMARY
Plasma volume (RIHSA) and peripheral plasma renin activity (Pickens' method) were measured in eight essential hypertensive patients treated with thiazide diuretics alone for periods ranging from 6 to 24 months. Treatment was then stopped and measurements repeated at weekly intervals for a month. During the first week of discontinuance, body weight and plasma volume rose in all (P < 0.001 for both), while peripheral plasma renin activity fell from 3.66 to 1.04 ng/ml (P < 0.005), and serum sodium concentration was practically unchanged. Over the next 3 weeks, both plasma volume and body weight gradually fell from the high first week "rebound" values to plateau at levels higher than those obtained during treatment (2741 vs. 2567 ml, P < 0.001 and 76.1 vs. 74.7 kg, P < 0.001, respectively). At the same time, peripheral plasma renin activity remained stable and markedly lower than during treatment (P <0.001), while blood pressure gradually rose. Extracellular water (ECW) was measured serially (radiobromine) in five patients; in all, body weight variations were completely accounted for by changes in ECW, and ratio of plasma to interstitial fluid volume remained stable. These data indicate that blood pressure reduction by longterm thiazide therapy was associated with persistent plasma volume contraction and occurred despite increased peripheral renin activity. There was no evidence for chronic intracellular dehydration, and variations in peripheral renin activity were related to changes in plasma volume and not to serum sodium concentration.
Alditional Indexing Words: Extracellular water
Arterial pressure Serum sodium CHRONIC THIAZIDE therapy undoubtedly has sustained antihypertensive'-4 and weight reducing5' 6 effects. Various reports have claimed that neither action is associated with persistent reduction in plasma volume,5-7 extracellular water,4 5 7 exchangeable sodium,4' 6, 7or cardiac output.8 Thus, the Study supported in part by a grant from the Heart Association of Northeastern Ohio and by Grant HE-6835 from the National Heart Institute, U. S. Public Health Service. Changes in Body Weight, Plasma Volume, and Blood Pressutre Thiazide Therapy discontinued. This indicates that a potent stimulus for sodium and water reabsorption has been evoked by this treatment, and it seems likely that this stimulus was related to contraction of the extracellular fluid compartment. These considerations, as well as lack of evidence for cellular depletion of sodium'5''", and the conceptual difficulty of ascribing sustained weight reduction to intracellular dehydration in active, normally fed subjects, led to a reexamination of former conclusions. (table 3) . The fifth patient (G.F.) followed the same trend but post-treatment plasma volume was 385 ml greater than the pre-treatment value.
In the first week without therapy, body weight and plasma volume rose significantly (P <0.001) and PRA fell from 3.66 to 1.04 ng/ml (P <0.005). In the subsequent 3 weeks of the study, both weight and plasma volume slowly declined from the first week's rebound values but never returned to treatment levels so that at the end of 4 weeks plasma volume and body weight were still significantly higher than during therapy (15.2 vs 17.0 ml/cm, P <0.001 and 74.7 vs. 76.1 kg, P <0.025, respectively). Plasma renin activity remained reduced with insignificant fluctuations. Arterial pressure rose slowly in all patients after treatment was discontinued and did not fluctuate as did weight and plasma volume ( fig. 1 ).
Extracellular water volume was determined in five patients just before treatment was stopped. In three this measurement was repeated twice, 1 week and again 4 weeks V;4 Cl-. following discontinuance of therapy. Freis.31 The extracellular fluid expansion and weight gains were obvious to both patient and observer and were always commented upon, sometimes bitterly. The evident puffiness and occasional dependent edema could not represent simple redistribution of water from intracellular to extracellular compartments since they were associated with definite weight increase. This rebound phenomenon seems difficult to explain on the basis of diminished intracellular water postulated by Lauwers and Conway,5 since any retention of water with stopping of treatment would first replenish the postulated intracellular dehydration. The rapid weight gain can speculatively be linked to chronic ECW contraction, since the latter is a stimulus to increased sodium reabsorption.36 With continued intake of thiazide effectively blocking this absorption the stimulus is thwarted; when diuretics are discontinued, the stimulus is unmasked and leads to the rebound peak observed.
Arterial pressure in essential hypertension is not dependent on intravascular volume as is the hypertension associated with renal parenchymal disease.37 This might explain the lack of fluctuations of arterial pressure with variations in plasma volume after cessation of therapy. The contrast between the slow pressure rise and the rapid rebound plasma volume peak does not, therefore, negate the role of volume reduction in the antihypertensive effects of thiazides. On the other hand, even a small reduction in blood volume may have a profound effect on arterial pressure if adequate reflex homeostasis is interfered with.'5' 3940 Thiazide interference with response to vasopressors10-12 or to nerve stimulation or both14 and their sustained decrease of peripheral resistance8 may well amplify the hypotensive effect of modest reductions in plasma volume noted by many2"' besides ourselves. This does not mean, however, that the blood pressure-lowering effect of thiazides is entirely due to volume reduction, since they often are effective even when given intermittently (5 days a week), and in our experience are thus less potent in maintaining a continuously contracted volume. Patients following this intermittent schedule often complain of weight gain and occasional puffiness during the days without diuretics; plasma volume measured in three subjects on the morning of the third day without thiazides was expanded to near pre-treatment levels.
Plasma renin activity is closely related to that functional, ill-defined entity called "effective blood volume."4' Though it is not strictly identical with intravascular volume, since blood distribution and vascular capacity are important factors in its definition, total blood and plasma volume, at least in the supine position, are valid indices of its function, since they have been demonstrated to be significantly related to PRA both in acute experiments'7 18 42 and in untreated normal and hypertensive subjects.'9 Thus, simultaneous measurement of PRA and PV may help evaluate the functional significance of a measured variation in the "10-minute albumin space." The increased plasma renin activity during thiazide treatment and its marked reduction in the first week after therapy are probably related to changes in plasma Circulation, Volume XLI, April 1970 volume (tables 1 and 2) and underline their significance.
Brown's group20' 21 has emphasized the importance of serum sodium in regulation of renin activity, especially when changes in serum sodium and plasma volume occur concomitantly as during thiazide treatment. However, variations in serum sodium were not significant in our patients (table 2) as was also the experience of others.'5' 29 Plasma volume and serum sodium thus changed in different ways during the first week of discontinuance ( fig. 1 
